|
Market Cap (19-May) $14,687,399 (777th) |
Close (30-Jun) $0.018 |
Volume (30-Jun) 1,123,417 |
Shortsold (11-Sep) 1,800,000 (0.12%) (439th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E 20.00 |
EPS -0.02 |
BNO released this announcement to the ASX on 26 February 2021, 14:38. The announcement is marked as price sensitive, and is 29 page(s) in length and 491.21kb in size.
You can view all announcements from BNO and see how they appear on a price chart on the announcements page.
At the date of this announcement, BNO was 0.015% short sold according to ASIC data. It was ranked the 563rd most shorted stock on the ASX. It is now ranked as the 439th most shorted stock on the ASX with 0.123% of total shares short sold as of the latest reported data (11 September 2023).
| Other Recent Announcements from BNO | |
|---|---|
| Poster Presentation at the ASCP Annual Meeting | 1 June 2023, 9:16 |
| Corporate Presentation - May 2023 | 23 May 2023, 9:24 |
| BNO announces establishment of At-The-Market Equity Program | 8 May 2023, 8:54 |
| Half Yearly Report and Accounts | 26 February 2021, 14:38 |
| Change in substantial holding | 24 February 2021, 10:03 |
| Positive BNC210 PK Results for Solid Dose Formulation | 22 February 2021, 9:35 |
| Bionomics and EmpathBio Joint Feasibility Assessment | 17 February 2021, 8:10 |
You must be logged in to post a reply.
Bionomics 